Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era

Current treatment guidelines for the management of recurrent glioblastoma (rGBM) are far from definitive, and the prognosis remains dismal. Despite recent advancements in the pharmacological and surgical fields, numerous doubts persist concerning the optimal strategy that clinicians should adopt for...

詳細記述

書誌詳細

出版年:	Biomedicines
主要な著者:	Augusto Leone, Antonio Colamaria, Nicola Pio Fochi, Matteo Sacco, Matteo Landriscina, Giovanni Parbonetti, Matteo de Notaris, Giulia Coppola, Elena De Santis, Guido Giordano, Francesco Carbone
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-08-01
主題:	recurrent glioblastoma brain tumor review glioblastoma treatment chemotherapy regorafenib
オンライン･アクセス:	https://www.mdpi.com/2227-9059/10/8/1927